Drosos Katsavelis

Mr. Drosos Katsavelis

MSc Biomedical Sciences UvA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NKNienke Koopman
Nienke Koopman
Drosos KatsavelisDrosos Katsavelis
Drosos Katsavelis
AHAnne S. Ten Hove
Anne S. Ten Hove
Stanley BrulStanley Brul
Stanley Brul
WJWouter de Jonge
Wouter de Jonge
JSJ.E. Seppen
J.E. Seppen
The monoamine serotonin, 5-hydroxytryptamine (5-HT), is a remarkable molecule with conserved production in prokaryotes and eukaryotes and a wide range of functions. In the gastrointestinal tract, enterochromaffin cells are the most important source for 5-HT production. Some intestinal bacterial species are also able to produce 5-HT. Besides its role as a neurotransmitter, 5-HT acts on immune cells to regulate their activation. Several lines of evidence indicate that intestinal 5-HT signaling is altered in patients with inflammatory bowel disease. In this review, we discuss the current knowledge on the production, secretion, and signaling of 5-HT in the intestine. We present an inventory of intestinal immune and epithelial cells that respond to 5-HT and describe the effects of these signaling processes on intestinal homeostasis. Further, we detail the mechanisms by which 5-HT could affect inflammatory bowel disease course and describe the effects of interventions that target intestinal 5-HT signaling.

26 August 2025 in Journal of Proteome Research
Verified
Journal Article
Open access
Drosos KatsavelisDrosos Katsavelis
Drosos Katsavelis
MHMarieke G. C. van der Hart
Marieke G. C. van der Hart
JWJustina Clarinda Wolters
Justina Clarinda Wolters
HPHjalmar Permentier
Hjalmar Permentier
PHPeter (GRIP) Horvatovich
Peter (GRIP) Horvatovich
TCThomas I.F.H. Cremers
Thomas I.F.H. Cremers
Serum proteomics plays a crucial role in biomarker discovery and disease research, yet the selection of an optimal sample preparation method remains challenging. Evaluating the accuracy of protein quantitation is of major importance and a vital part of a benchmarking study in proteomics, since clinical studies are based on the differential expression of certain proteins that can be used as biomarkers or be indicative of a pathological state. In this study, we performed a direct comparison of 6 widely used serum proteomic sample preparation workflows: In-gel digestion (IGD), Single-Pot Solid-Phase-enhanced Sample Preparation (SP3), Top 14 Abundant Protein Depletion (Top 14), Isopropanol/Trichloroacetic Acid (IPA/TCA) precipitation, PreOmics ENRICH-iST (PreOmics), and Seer Proteograph XT (Seer). Seer and PreOmics demonstrated superior quantitative accuracy, especially for proteins with low abundance in serum, while the Seer enrichment approach provided the highest number of protein identifications (>2000) as measured by an Orbitrap Exploris 480. All methods had median CVs close to or below 20%. This comparative analysis provides a comprehensive resource for selecting the most appropriate serum sample preparation strategy based on specific experimental needs, facilitating human serum proteomic profiling for biomedical research.

29 July 2026 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
FCFabio Catalano
Fabio Catalano
DSDejan Stevic
Dejan Stevic
GZGiacomo Zundo
Giacomo Zundo
THTessa F Huizer
Tessa F Huizer
ZDZina Dammou
Zina Dammou
W.W.M. Pim PijnappelW.W.M. Pim Pijnappel
W.W.M. Pim Pijnappel

10 September 2026 in Journal of Proteome Research
Verified
Journal Article
Open access
Drosos KatsavelisDrosos Katsavelis
Drosos Katsavelis
MHMarieke G. C. van der Hart
Marieke G. C. van der Hart
JWJustina C. Wolters
Justina C. Wolters
HPHjalmar Permentier
Hjalmar Permentier
PHPeter (GRIP) Horvatovich
Peter (GRIP) Horvatovich
TCThomas I.F.H. Cremers
Thomas I.F.H. Cremers
Advances in mass spectrometry (MS) instrumentation and protein extraction technologies are reshaping proteomics; however, whether improved analytical performance alters the biological information accessible from different sample preparation strategies remains unclear. Here, we performed a cross-platform evaluation using identical benchmark serum samples previously analyzed on an Orbitrap Exploris 480 platform, including the newly introduced Seer Proteograph ONE workflow, to determine how MS advances and sample preparation influence analytical performance and biological interpretation. Across all preparation strategies, the timsTOF HT improved analytical performance by increasing protein and peptide identifications, reducing missing values, and improving linearity in spike-in experiments, particularly for low-abundance proteins. Despite these improvements, sample preparation remained the major determinant of the accessible serum proteome. Functional enrichment analysis revealed reproducible workflow-specific biases across MS platforms: nanoparticle-based enrichment expanded access to a broader range of serum proteins and improved detection of clinically relevant signaling-associated proteins, including cytokine- and chemokine-related marker classes, whereas the depletion-based strategy showed a distinct functional profile enriched for receptor-related activities. Together, these findings demonstrate that MS advances enhance analytical performance but do not eliminate sample preparation-driven differences in biological accessibility. This study provides a framework for selecting serum proteomics workflows according to specific biomarker and pathway objectives.

29 September 2025 in EMBO Molecular Medicine
Verified
Journal Article
Open access
FCFabio Catalano
Fabio Catalano
DSDejan Stevic
Dejan Stevic
GZGiacomo Zundo
Giacomo Zundo
THTessa F Huizer
Tessa F Huizer
ZDZina Dammou
Zina Dammou
W.W.M. Pim PijnappelW.W.M. Pim Pijnappel
W.W.M. Pim Pijnappel
We present the SWAP design, a novel, structurally cohesive IGF2-based tag for modular receptor targeting during gene therapy for lysosomal storage disorders (LSDs). We found that IGF2’s central loop is critical for high-affinity binding to the insulin receptor (IR) and IGF1 receptor (IGF1R)—both involved in glucose homeostasis—but is not required for interaction with the cation independent mannose 6-phosphate/IGF2 receptor (CI-M6P/IGF2R)—a key target for lysosomal delivery. This formed the basis for designing the Substitution of the central-loop With Augmenting Peptides (SWAP) tag. By replacing the central loop with alternative epitopes, SWAP ensures high-affinity multimodal receptor targeting while maintaining structural integrity. In vivo, lentiviral gene therapy employing IDS fused to SWAP variants containing ApoE and RAP12x2 inserts corrected Hunter disease pathology across multiple tissues, including liver, spleen, heart, bone, and brain, matching the efficacy of the traditional IGF2 tag. These findings position SWAP as a novel and effective tag design for IGF2-based therapeutics with a more favourable ligand–receptor interaction.